SCHEMBL17652127

SCHEMBL17652127

NC(=O)NC(=O)N[N+](=O)[O-]

nearest known ligand 0.36

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 1/20 0.36
LMNA P02545 4/20 0.33
CYP1A2 P05177 2/20 0.31
POLB P06746 1/20 0.31
TSHR P16473 2/20 0.30
NFKB1 P19838 2/20 0.30
MAOA P21397 1/20 0.30
MAOB P27338 1/20 0.30
THPO P40225 1/20 0.30
CA2 P00918 1/20 0.30
CYP3A4 P08684 1/20 0.30
CA5A P35218 1/20 0.30
BLM P54132 1/20 0.30
PMP22 Q01453 1/20 0.30
CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11809119 0.81 ALDH1A1 (0.35) LMNA
SCHEMBL304553 0.78
SCHEMBL3072776 0.76 LMNA (0.38) CRBNLMNA
Methane SCHEMBL3764799 0.76
SCHEMBL30230076 0.76
SCHEMBL11470161 0.76
SCHEMBL28874017 0.76
SCHEMBL30363497 0.76
SCHEMBL20587385 0.74
Nitric Acid SCHEMBL25282444 0.73 CA5A (0.50) CRBNLMNACYP1A2TSHRNFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107207448-B Antimicrobial compounds, methods of making the same, and articles comprising the same 医学科技研究公司 2020-12-29 CN claimed
US-10189798-B2 Antimicrobial compounds, methods of making the same and articles comprising them MEDICAL TECHNOLOGY RESEARCH INC (US) 2019-01-29 US claimed
US-20180134672-A1 ANTIMICROBIAL COMPOUNDS, METHODS OF MAKING THE SAME AND ARTICLES COMPRISING THEM MEDICAL TECHNOLOGY RESEARCH INC 2018-05-17 US claimed
EP-3201182-A2 ANTIMICROBIAL COMPOUNDS, METHODS OF MAKING THE SAME AND ARTICLES COMPRISING THEM Medical Technology Research Inc. (US) 2017-08-09 EP claimed
WO-2016054284-A2 ANTIMICROBIAL COMPOUNDS, METHODS OF MAKING THE SAME AND ARTICLES COMPRISING THEM MEDICAL TECHNOLOGY RESEARCH INC (US) 2016-04-07 WO claimed
CN-109641842-B 1-phenyl-3-carbamoylurea compounds and uses thereof 住友化学株式会社 2021-12-07 CN disclosed
CN-107207448-B Antimicrobial compounds, methods of making the same, and articles comprising the same 医学科技研究公司 2020-12-29 CN disclosed
US-10844019-B2 1-phenyl-3-carbamoyl urea compound, and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2020-11-24 US disclosed
CN-107573263-B Synthetic method of omega-substituted biuret compound 大连理工大学 2020-04-07 CN disclosed
US-20190202787-A1 1-PHENYL-3-CARBAMOYL UREA COMPOUND, AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2019-07-04 US disclosed
CN-109641842-A 1- phenyl -3- carbamoyl carbamide compound and application thereof 住友化学株式会社 2019-04-16 CN disclosed
US-10189798-B2 Antimicrobial compounds, methods of making the same and articles comprising them MEDICAL TECHNOLOGY RESEARCH INC (US) 2019-01-29 US disclosed
US-20180134672-A1 ANTIMICROBIAL COMPOUNDS, METHODS OF MAKING THE SAME AND ARTICLES COMPRISING THEM MEDICAL TECHNOLOGY RESEARCH INC 2018-05-17 US disclosed
CN-107573263-A A kind of synthetic method of ω substitutions biuret class compound 大连理工大学 2018-01-12 CN disclosed
CN-107207448-A Antimicrobial compounds, methods of making the same, and articles comprising the same 医学科技研究公司 2017-09-26 CN disclosed
EP-3201182-A2 ANTIMICROBIAL COMPOUNDS, METHODS OF MAKING THE SAME AND ARTICLES COMPRISING THEM Medical Technology Research Inc. (US) 2017-08-09 EP disclosed
WO-2016054284-A2 ANTIMICROBIAL COMPOUNDS, METHODS OF MAKING THE SAME AND ARTICLES COMPRISING THEM MEDICAL TECHNOLOGY RESEARCH INC (US) 2016-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10189798-B2 Antimicrobial compounds, methods of making the same and articles comprising them GSDMD, TIAL1, AAAS CRBN 1309/4885LMNA 4714/4885CYP1A2 2158/4885
US-20180134672-A1 ANTIMICROBIAL COMPOUNDS, METHODS OF MAKING THE SAME AND ARTICLES COMPRISING THEM GSDMD, TIAL1, AAAS CRBN 1309/4885LMNA 4714/4885CYP1A2 2158/4885
US-10844019-B2 1-phenyl-3-carbamoyl urea compound, and use thereof CPS1, SLC14A1, UBA1 CRBN 2179/4885LMNA 3310/4885CYP1A2 2538/4885
US-20190202787-A1 1-PHENYL-3-CARBAMOYL UREA COMPOUND, AND USE THEREOF CPS1, SLC14A1, UBA1 CRBN 2179/4885LMNA 3310/4885CYP1A2 2538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.